Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$27.34 - $55.37 $3.69 Million - $7.46 Million
134,786 New
134,786 $3.81 Million
Q4 2022

Feb 14, 2023

SELL
$16.24 - $26.38 $626,539 - $1.02 Million
-38,580 Reduced 65.29%
20,512 $383,000
Q3 2022

Nov 14, 2022

BUY
$23.95 - $34.71 $1.04 Million - $1.51 Million
43,435 Added 277.42%
59,092 $1.48 Million
Q2 2022

Aug 15, 2022

BUY
$21.39 - $35.9 $334,903 - $562,086
15,657 New
15,657 $414,000
Q1 2022

May 09, 2022

SELL
$24.84 - $36.12 $241,941 - $351,808
-9,740 Closed
0 $0
Q4 2021

Feb 01, 2022

BUY
$33.38 - $59.25 $194,104 - $344,538
5,815 Added 148.15%
9,740 $339,000
Q3 2021

Nov 12, 2021

BUY
$53.75 - $76.55 $210,968 - $300,458
3,925 New
3,925 $215,000

Others Institutions Holding SDGR

About Schrodinger, Inc.


  • Ticker SDGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 62,028,400
  • Market Cap $1.23B
  • Description
  • Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences i...
More about SDGR
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.